Status:
UNKNOWN
Acute Kidney Injury and Renal Outcomes for COVID-19 Patients in Intensive Care Units
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
on Occurrence of Acurate Kidney Injury During Intensive Care Unit
Abnormalities of Urinary Analysis
Eligibility:
All Genders
18+ years
Brief Summary
The actual COVID-19 epidemy is an unprecedented healthcare problem. Although acute respiratory distress syndrome is the main organ failure, acute kidney injury (AKI) has appeared to be more frequent a...
Eligibility Criteria
Inclusion
- Confirmed COVID-19 infection (by qRT-PCR and/or TDM typical lesion)
- Needing intensive care
Exclusion
- End Stage Renal Disease patients (with pre-existent dialysis)
- Intensive care support for less than 72h (transfer in conventional unit or death)
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04459975
Start Date
April 1 2020
End Date
November 1 2020
Last Update
July 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Intensive care units attached to the Hospices Civils de Lyon (HCL)
Lyon, France, 69002